Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Sept 2022 for NovaBay Pharmaceuticals, Inc., €1,502. Read the official filing
Filing timeline
BuySaleJustin Hall
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Justin Hall: trading record in brief
This profile gathers the share dealings of Justin Hall in Stablecoin Development Corp, where the filings describe the role as chief executive. Between 6 December 2021 and 14 September 2022, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 2 purchases, €28k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2022 alone, the filings show 1 purchase and no sales.
The newest entry dates from 16 September 2022: an open-market purchase of €1,502, in Stablecoin Development Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Justin Hall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares@ US$0.152.8% of flowCommon StockSEC:0001437749-22-022651:0
Canonical exit: 13 Dec 2022 (T+90)
69,767 shares@ US$0.4394.6% of flowCommon StockSEC:0001437749-21-027958:0
Canonical exit: 6 Mar 2022 (T+90)
2 of 2 declarations
